It is a global pharmaceutical Company operating in over 30 countries worldwide (Europe, Arab countries and sub-Saharan Africa).

The pharmaceutical Group is certified by many eminent International agencies.
The various specialized product lines designed as per GMP requirements enable SOTHEMA to meet the need for manufacturing many complex therapeutic medications of some Moroccan and Multinational laboratories.
SOTHEMA is creating innovative generic products by improving and expanding use of known compounds.

Moreover, it strengthens its pharmaceutical portfolio through development and licensing.
To be more International, SOTHEMA implements its vision of investing by spreading subsidiaries such as WAPH (West Afric Pharma) in Senegal.
SOTHEMA is actively operating in Libyan Market and is reinforcing its presence